Clinical trials
Phase 3 trials in Jordan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Active, not recruiting | 20 |
| Terminated | 8 |
| Recruiting | 6 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 17 |
| Shire | 4 |
| Hoffmann-La Roche | 3 |
| Pfizer | 3 |
| Regeneron Pharmaceuticals | 3 |
| University of Jordan | 3 |
| argenx | 3 |
| Boehringer Ingelheim | 2 |
| Janssen Pharmaceutica N.V., Belgium | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Angioedemas, Hereditary | 4 |
| Multiple Sclerosis | 4 |
| Anemia, Sickle Cell | 2 |
| Hemoglobinuria, Paroxysmal | 2 |
| Myeloproliferative Disorders | 2 |
| Purpura, Thrombocytopenic, Idiopathic | 2 |
| Recurrence | 2 |
| Schizophrenia | 2 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.